What Drugs Should Not Be Taken With Losartan?

Losartan, one of the most widely prescribed blood pressure medications, has a handful of drug interactions that range from mildly inconvenient to genuinely dangerous. The most clinically significant involve common painkillers like ibuprofen, potassium-raising agents, lithium, certain antifungal drugs, and other medications that block the same blood-pressure system losartan targets. Because losartan depends on a specific liver enzyme to become fully active, anything that interferes with that enzyme can also change how well the drug works or how much of it accumulates in your body.

NSAIDs and the Triple Whammy

Non-steroidal anti-inflammatory drugs, the category that includes ibuprofen, naproxen, and prescription options like diclofenac and celecoxib, are among the most common medications that cause trouble with losartan. On their own, NSAIDs slightly raise blood pressure and reduce kidney blood flow. Paired with losartan, those effects become more pronounced because both drugs push kidney function in opposing directions. Losartan relaxes the blood vessels leaving the kidney’s filtering units, while NSAIDs constrict the vessels entering them. The net result is a drop in filtration pressure that can quietly erode kidney function over weeks or escalate into acute kidney injury if you are dehydrated or unwell.

The risk jumps further when a diuretic (water pill) is in the mix. Researchers have a blunt name for the combination of a blood-pressure drug like losartan, a diuretic, and an NSAID: the “triple whammy.” A study tracking hospitalizations for acute kidney injury found an incidence of about 3.4 cases per 1,000 users per year among people on all three drug classes, with roughly four out of five affected patients over the age of 70.¹ A separate modeling study confirmed that the concurrent use of a diuretic, a renin-angiotensin system inhibitor like losartan, and an NSAID significantly raises the odds of acute kidney injury.²

What makes this interaction so troublesome in everyday life is that people often reach for ibuprofen or naproxen without thinking of them as “real” medications. If you take losartan daily, especially alongside a diuretic like hydrochlorothiazide (which is often combined with losartan in a single pill), even a short course of over-the-counter ibuprofen for a headache or sore knee adds risk. Acetaminophen (paracetamol) is the safer alternative for routine pain when you are on losartan, because it does not affect kidney blood flow the way NSAIDs do.

Potassium-Raising Medications and Supplements

Losartan belongs to a class called angiotensin receptor blockers (ARBs), and one of the predictable effects of blocking the angiotensin system is that your kidneys hold on to more potassium than usual. For most people, this shift is small and harmless. It becomes a problem when other potassium-raising factors stack on top of it.

The main culprits are potassium-sparing diuretics like spironolactone, eplerenone, amiloride, and triamterene. These drugs deliberately reduce potassium loss in the urine, which is useful in some heart failure and hormonal conditions but dangerous when combined with an ARB without close monitoring. Potassium supplements, including the effervescent tablets sometimes recommended for leg cramps, add to the load. Even potassium-based salt substitutes, marketed as a heart-healthy alternative to regular table salt, can push levels high enough to cause irregular heart rhythms if you are already on losartan.

Mild high potassium often produces no symptoms at all, which is why routine blood work matters. Severe cases can cause muscle weakness, tingling, and cardiac arrhythmias. Monitoring potassium and creatinine levels is a standard recommendation for anyone on an ARB.³ Your doctor will typically check these shortly after starting losartan and periodically thereafter, but that schedule should be tightened whenever a new potassium-affecting drug is added.

ACE Inhibitors and Dual Blockade of the Same System

Losartan and ACE inhibitors like lisinopril, enalapril, and ramipril both target the renin-angiotensin-aldosterone system (RAAS), but they do so at different points. In theory, blocking the system at two sites simultaneously could provide stronger blood-pressure control or better kidney protection. In practice, large trials have shown that dual RAAS blockade increases the risk of dangerously low blood pressure, high potassium, and acute kidney injury without a reliable survival benefit for most patients. Current guidelines from major cardiology societies generally advise against combining an ARB with an ACE inhibitor.

There are narrow exceptions. In some heart failure patients, adding an ARB to an ACE inhibitor has been studied, and a small trial of losartan added to ACE inhibitor therapy in mild-to-moderate heart failure reported that the combination was tolerated without significant changes in serum creatinine or potassium over 12 weeks.⁴ But tolerability in a short controlled trial is not the same as long-term safety in a broader population, and the consensus has moved firmly away from dual blockade as a routine strategy. If your cardiologist has you on both, they are almost certainly monitoring you closely and have a specific clinical reason.

Lithium

Lithium, used primarily for bipolar disorder, has one of the narrowest therapeutic windows of any commonly prescribed drug. Even small increases in blood lithium levels can tip a person from a therapeutic dose into toxicity, which can cause tremor, confusion, seizures, and kidney damage. Losartan raises lithium levels by a well-understood mechanism: it reduces the kidney’s filtration rate and promotes sodium loss, both of which cause the kidney to reabsorb more lithium from the urine back into the bloodstream.⁵

This interaction is not unique to losartan; all ARBs and ACE inhibitors can do it. But the consequences are serious enough that anyone taking lithium who starts losartan, or vice versa, needs more frequent lithium level checks, particularly in the first few weeks. Dehydration, illness, or the addition of a diuretic can amplify the effect further. If you are on lithium and your doctor prescribes losartan, do not assume the doses will stay the same. Expect a period of closer monitoring.

Drugs That Alter Losartan’s Liver Metabolism

Losartan is somewhat unusual among blood-pressure drugs because it is actually a prodrug. The tablet you swallow is not the most active form of the medication. Your liver converts losartan into a metabolite called E-3174, which is substantially more potent at blocking angiotensin receptors than losartan itself. This conversion happens primarily through a liver enzyme called CYP2C9, with some contribution from CYP3A4.⁶ Anything that speeds up or slows down CYP2C9 can meaningfully change how well losartan works.

CYP2C9 Inhibitors

Fluconazole, a common antifungal prescribed for yeast infections, is one of the strongest CYP2C9 inhibitors people encounter in routine medical care. When healthy volunteers took fluconazole alongside losartan, the levels of losartan in their blood rose by about two-thirds, while the levels of the active metabolite E-3174 dropped by roughly half.⁷ A separate study found a similar pattern, with E-3174 peak levels falling to about 30% of normal during fluconazole use.⁸ The practical upshot is that fluconazole can blunt losartan’s blood-pressure-lowering effect because less of the active metabolite is being formed. This is a concern for short courses (a one-time dose for a vaginal yeast infection is unlikely to matter much), but a week or more of fluconazole could meaningfully reduce losartan’s effectiveness.

Interestingly, itraconazole, another antifungal, did not significantly affect losartan metabolism in the same study. That distinction matters because not all antifungals are interchangeable when it comes to drug interactions. Itraconazole primarily inhibits CYP3A4 rather than CYP2C9, and while CYP3A4 does contribute to losartan’s conversion, CYP2C9 is the dominant pathway. Other drugs that inhibit CYP2C9, such as amiodarone (a heart rhythm drug) and some newer anticoagulants, could theoretically have a similar dampening effect on losartan activation, though the clinical data for those pairings is thinner.

CYP Inducers

On the opposite end, drugs that speed up CYP enzymes can cause your body to clear losartan faster than intended. Rifampin, an antibiotic used mainly for tuberculosis, is one of the most powerful enzyme inducers in clinical use. In a study of healthy volunteers, rifampin reduced the levels of both losartan and its active metabolite by roughly 35 to 40%, cut their half-lives in half, and increased losartan’s clearance by about 44%.⁹ The result is that losartan’s blood-pressure-lowering power drops substantially. If you need both drugs, your doctor may need to increase the losartan dose or switch to a different blood-pressure medication that rifampin does not affect as strongly. St. John’s wort, an herbal supplement used for depression, is another CYP inducer that could reduce losartan’s effectiveness, though formal studies specific to this pairing are limited.

Blood Sugar Medications

If you have type 2 diabetes and take losartan, you may have heard that losartan can improve insulin sensitivity. Animal studies support this idea, showing that losartan treatment in diabetic rats significantly lowered both insulin levels and blood glucose.¹⁰ That is generally seen as a bonus, since many people with high blood pressure also have insulin resistance. But it creates a wrinkle when losartan is combined with certain diabetes drugs, particularly sulfonylureas like glimepiride.

A study in diabetic rats found that prolonged losartan pretreatment amplified glimepiride’s blood-sugar-lowering effect, possibly through improved insulin sensitivity and inhibition of CYP2C9, the same enzyme losartan itself relies on for activation.¹¹ The practical concern is that the combination might push blood sugar lower than expected, raising the risk of hypoglycemia. This is worth mentioning to your doctor if you notice more frequent episodes of low blood sugar after starting losartan, particularly if your diabetes is managed with a sulfonylurea. Metformin, the most commonly prescribed diabetes drug, does not share this interaction profile, and most people on both metformin and losartan do not run into issues.

Losartan During Pregnancy

This is not a drug interaction in the traditional sense, but it is arguably the most critical safety warning associated with losartan. All drugs that block the renin-angiotensin system, including both ACE inhibitors and ARBs like losartan, can cause severe harm to a developing fetus. Exposure during the second and third trimesters has been linked to decreased amniotic fluid, underdeveloped lungs and skull bones, kidney failure in the newborn, and fetal death.¹²

A systematic review of pregnancy outcomes following exposure to ACE inhibitors and ARBs confirmed that neonatal complications from ARBs were frequent and included renal failure, low blood pressure, growth restriction, respiratory distress, and limb defects.¹³ Evidence on first-trimester exposure is less conclusive for birth defects specifically, but the drug’s toxic effects on the fetus in later pregnancy are well-established enough that ARBs should not be used by pregnant women at any stage.¹⁴ If you become pregnant while taking losartan, contact your doctor promptly to switch to a pregnancy-safe alternative. Methyldopa, labetalol, and nifedipine are the usual replacements for managing blood pressure during pregnancy.

Medical Conditions That Amplify the Risk

Certain underlying conditions make losartan riskier regardless of other medications. Bilateral renal artery stenosis, a condition in which both arteries supplying the kidneys are narrowed, is the classic example. In healthy kidneys, losartan’s effect on the angiotensin system is well tolerated. But when blood flow to the kidneys is already compromised by narrowed arteries, removing the angiotensin-driven constriction on the kidney’s outflow vessels can cause filtration to collapse entirely. Case reports have documented acute kidney failure in patients with bilateral renal artery stenosis after starting losartan.¹⁵ The same applies to patients with a single functioning kidney and stenosis in its artery.¹⁶

Severe heart failure and significant volume depletion (from vomiting, diarrhea, or heavy diuretic use) can create a similar vulnerability, because in those states the kidneys become highly dependent on angiotensin to maintain filtration. Starting losartan, or adding another drug that lowers blood pressure or fluid volume, in any of those situations requires extra caution and close lab monitoring.

Genetic Variation in Losartan Metabolism

Not everyone converts losartan to its active metabolite at the same rate, and the main reason is genetic variation in the CYP2C9 enzyme. The “normal” version of the gene is called CYP2C9*1. People who carry variant forms, particularly CYP2C9*2 or *3, produce a slower version of the enzyme. A meta-analysis found that carriers of these variants had higher blood levels of losartan itself and lower levels of the active metabolite E-3174 compared to people with the standard gene version, along with longer half-lives for both compounds.¹⁷

In practical terms, this means some people are inherently “poor metabolizers” of losartan and may not get the full blood-pressure benefit from standard doses. These same individuals are also more sensitive to CYP2C9 inhibitors like fluconazole, because their already-slow enzyme gets suppressed further. Pharmacogenomic testing for CYP2C9 status is available but not routinely ordered for losartan. It is more commonly checked when a patient seems to respond poorly to the drug or experiences unusual side effects. If you carry a variant and your doctor is aware of it, they may choose a different ARB that does not depend on CYP2C9, such as valsartan or irbesartan.

Food, Grapefruit, and Timing

Compared to many medications, losartan is fairly forgiving about food. One pharmacokinetic study showed that eating a meal delayed losartan absorption, roughly doubling the time to peak blood levels, and modestly shifted the drug’s overall exposure: total absorption increased by about 14% while peak concentration dipped by about 16%.¹⁸ These changes are small enough that losartan can be taken with or without food, and most prescribing guidelines do not specify one way or the other.

Grapefruit and grapefruit juice, which famously interfere with CYP3A4, have a less dramatic effect on losartan than on drugs that depend entirely on that enzyme. Since losartan’s primary activation pathway runs through CYP2C9 rather than CYP3A4, occasional grapefruit consumption is unlikely to cause a clinically meaningful shift. That said, large daily quantities of grapefruit juice could contribute to a modest change in drug levels, and people who are already poor CYP2C9 metabolizers may have less margin for any additional enzyme disruption. The simpler advice: moderate grapefruit intake is fine for most people on losartan, but if you are drinking it by the glass every day, mention it to your pharmacist.

Commonly Overlooked Interactions

A few interactions tend to fly under the radar because the offending substances are not prescription drugs. Potassium-based salt substitutes, already mentioned above, are the prime example. They are sold as a health product and used liberally by people trying to reduce sodium, many of whom are the same patients taking losartan for hypertension. The combination can quietly raise potassium to concerning levels, especially in older adults with some degree of kidney function decline.

Herbal supplements are another blind spot. St. John’s wort induces CYP enzymes and could reduce losartan’s effectiveness. Licorice root (real licorice, not the candy flavored with anise) can raise blood pressure and cause potassium loss through a different hormonal mechanism, potentially counteracting losartan’s intended effect. Neither supplement is likely to come up in a standard medication review unless you specifically mention it.

Alcohol does not have a formal drug interaction with losartan, but both lower blood pressure. In combination, especially in the first few hours after taking losartan, the additive blood-pressure drop can cause dizziness or lightheadedness. This is more of a pharmacological overlap than a true interaction, but it is worth knowing about if you tend to feel unsteady after a drink. Staying well hydrated and standing up slowly are the usual practical fixes.